Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Spectral Filtering in a Spectrally Adjustable Ocular Photosensitivity Analyzer

NCT04811079 is registered in ClinicalTrials.gov with Johnson & Johnson Vision Care, Inc. as lead sponsor.

NCT NCT04811079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04811079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Spectral Filtering in a Spectrally Adjustable Ocular Photosensitivity Analyzer
Lead sponsor
Johnson & Johnson Vision Care, Inc.
Phase
Not applicable
Overall status
Completed
Start date
July 14, 2021
Completion date
May 16, 2022
Enrollment
53 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

photosensitivity